Navigation Links
Accuray Hosts Symposium on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
Date:7/20/2011

SUNNYVALE, Calif., July 20, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will host a symposium examining best practices for quality assurance in radiation oncology at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) Meeting. The symposium—"Best Quality Assurance Programs for Today's Radiation Oncology Platforms"—will discuss how systems' engineering principles can be applied to radiotherapy quality assurance (QA) and quality compliance (QC). The 2011 Joint AAPM/COMP Meeting takes place July 31-August 4, 2011 in Vancouver, British Columbia.WHO:Sonja Dieterich, Ph.D., DABR, Chief of Clinical Physics at Stanford University School of Medicine, and Sasa Mutic, Ph.D., Chief of Clinical Medical Physics and Associate Professor of Radiation Oncology at Washington University School of MedicineWHAT:A complimentary luncheon and discussion of best practices for QA in radiation oncology. The symposium will also discuss the protocols and recommendations of task group TG-135, which has been dedicated to setting QA standards in the field of robotic radiosurgery.WHEN:Monday, August 1, 201112:30 PM to 2:00 PM PDTWHERE:The 2011 Joint AAPM/COMP Meeting Fairmont Pacific RimSapphire Ballroom1038 Canada PlaceVancouver, British ColumbiaWHY:Precision radiosurgery and intensity-modulated radiotherapy require strict QA to ensure safe operation. This symposium will highlight QC measurements and QA procedures that can minimize adverse results related to Accuray's technologies including the CyberKnife® Robotic Radiosurgery System and the TomoTherapy® Radiation Therapy System.HOW: Attendees interested in participating in the symposium may register online.About AccurayAccuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's game-changing technologies – the CyberKnife System and TomoTherapy System – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
Euan Thomson, Ph.D.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accurays CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer
2. Accuray Hosts Korean Embassys Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement
3. Accuray Successfully Completes Acquisition of TomoTherapy
4. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
5. Accuray Incorporateds CEO to Speak at Jefferies 2011 Global Healthcare Conference
6. Accuray Showcases CyberKnife Robotic Radiosurgery System at American Urological Association Meeting
7. Accuray Announces Results for Third Quarter of Fiscal 2011
8. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
9. Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
10. Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
11. Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... and PETACH TIKVAH, Israel , ... BCLI), a leading developer of adult stem cell technologies ... quarter ending June 30, 2017. ... preparing for our pivotal Phase 3 trial to investigate ... , President and Chief Executive Officer of BrainStorm. "We ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
Breaking Medicine Technology:
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... IN (PRWEB) , ... August 18, 2017 , ... Inc. ... annual list, the most prestigious ranking of the nation's fastest-growing private companies. This marks ... the exclusive Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 percent ...
(Date:8/18/2017)... ... ... “Dangerous Inheritance”: a mystery about saving the family farm. “Dangerous Inheritance” is ... she was raised on a farm. As Diane wrote this story, she used ... and mantra of ‘neighbors helping neighbors’ have always been a large part of her ...
Breaking Medicine News(10 mins):